COVID-19-associated immune thrombocytopenia
The coronavirus disease 2019 (COVID-19) is a contagious respiratory tract infection caused by the betacoronavirus SARS-CoV-2. The World Health Organization declared the COVID-19 outbreak a pandemic on March 11, 2020. Since the COVID-19 pandemic started, more than 166 million patients have been teste...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Amaltea Medical Publishing House
2021-06-01
|
| Series: | Romanian Journal of Infectious Diseases |
| Subjects: | |
| Online Access: | https://rjid.com.ro/articles/2021.2/RJID_2021_2_Art-01.pdf |
| _version_ | 1828552773041389568 |
|---|---|
| author | Mara-Andrada Plesu Gabriel Cristian Bejan Ioana Veronica Grajdeanu Anca Angela Simionescu Ana Maria Alexandra Stanescu |
| author_facet | Mara-Andrada Plesu Gabriel Cristian Bejan Ioana Veronica Grajdeanu Anca Angela Simionescu Ana Maria Alexandra Stanescu |
| author_sort | Mara-Andrada Plesu |
| collection | DOAJ |
| description | The coronavirus disease 2019 (COVID-19) is a contagious respiratory tract infection caused by the betacoronavirus SARS-CoV-2. The World Health Organization declared the COVID-19 outbreak a pandemic on March 11, 2020. Since the COVID-19 pandemic started, more than 166 million patients have been tested positive worldwide with more than 3.4 million related death recorded. COVID-19 has a wide range of signs and symptoms. Hematological changes such as lymphopenia, thrombocytopenia, and coagulation disturbances are not unusual in patients with COVID-19. However, the mechanisms causing these changes are partially comprehended. Immune thrombocytopenia was identified to be among the hematologic autoimmune diseases seen in patients infected with SARS-CoV-2. This review summarizes the evidence on COVID-19-associated immune thrombocytopenia and the underlying mechanisms involved in its development. |
| first_indexed | 2024-12-12T05:06:00Z |
| format | Article |
| id | doaj.art-f29dee1b6daa47eea30b1905d4e44d9d |
| institution | Directory Open Access Journal |
| issn | 1454-3389 2069-6051 |
| language | English |
| last_indexed | 2024-12-12T05:06:00Z |
| publishDate | 2021-06-01 |
| publisher | Amaltea Medical Publishing House |
| record_format | Article |
| series | Romanian Journal of Infectious Diseases |
| spelling | doaj.art-f29dee1b6daa47eea30b1905d4e44d9d2022-12-22T00:37:06ZengAmaltea Medical Publishing HouseRomanian Journal of Infectious Diseases1454-33892069-60512021-06-01242637010.37897/RJID.2021.2.1COVID-19-associated immune thrombocytopeniaMara-Andrada Plesu0Gabriel Cristian Bejan1Ioana Veronica Grajdeanu2Anca Angela Simionescu3Ana Maria Alexandra Stanescu4Private Medical Practice Dr. Ioana Veronica Grajdeanu, Bucharest, RomaniaDepartment of Family Medicine, “Carol Davila” University of Medicine and Pharmacy, Bucharest, RomaniaDepartment of Family Medicine, “Carol Davila” University of Medicine and Pharmacy, Bucharest, RomaniaDepartment of Obstetrics and Gynecology, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania; Filantropia Clinical Hospital, Bucharest, RomaniaDepartment of Family Medicine, “Carol Davila” University of Medicine and Pharmacy, Bucharest, RomaniaThe coronavirus disease 2019 (COVID-19) is a contagious respiratory tract infection caused by the betacoronavirus SARS-CoV-2. The World Health Organization declared the COVID-19 outbreak a pandemic on March 11, 2020. Since the COVID-19 pandemic started, more than 166 million patients have been tested positive worldwide with more than 3.4 million related death recorded. COVID-19 has a wide range of signs and symptoms. Hematological changes such as lymphopenia, thrombocytopenia, and coagulation disturbances are not unusual in patients with COVID-19. However, the mechanisms causing these changes are partially comprehended. Immune thrombocytopenia was identified to be among the hematologic autoimmune diseases seen in patients infected with SARS-CoV-2. This review summarizes the evidence on COVID-19-associated immune thrombocytopenia and the underlying mechanisms involved in its development.https://rjid.com.ro/articles/2021.2/RJID_2021_2_Art-01.pdfthrombocytopeniaimmune thrombocytopenic purpuracovid-19sars-cov-2coronavirus |
| spellingShingle | Mara-Andrada Plesu Gabriel Cristian Bejan Ioana Veronica Grajdeanu Anca Angela Simionescu Ana Maria Alexandra Stanescu COVID-19-associated immune thrombocytopenia Romanian Journal of Infectious Diseases thrombocytopenia immune thrombocytopenic purpura covid-19 sars-cov-2 coronavirus |
| title | COVID-19-associated immune thrombocytopenia |
| title_full | COVID-19-associated immune thrombocytopenia |
| title_fullStr | COVID-19-associated immune thrombocytopenia |
| title_full_unstemmed | COVID-19-associated immune thrombocytopenia |
| title_short | COVID-19-associated immune thrombocytopenia |
| title_sort | covid 19 associated immune thrombocytopenia |
| topic | thrombocytopenia immune thrombocytopenic purpura covid-19 sars-cov-2 coronavirus |
| url | https://rjid.com.ro/articles/2021.2/RJID_2021_2_Art-01.pdf |
| work_keys_str_mv | AT maraandradaplesu covid19associatedimmunethrombocytopenia AT gabrielcristianbejan covid19associatedimmunethrombocytopenia AT ioanaveronicagrajdeanu covid19associatedimmunethrombocytopenia AT ancaangelasimionescu covid19associatedimmunethrombocytopenia AT anamariaalexandrastanescu covid19associatedimmunethrombocytopenia |